Calcium channel blockers versus other classes of drugs for hypertension
Jiaying Zhu, Ning Chen, Muke Zhou, Jian Guo, Cairong Zhu, Jie Zhou, Mengmeng Ma, Li He
Abstract
This is the first update of a review published in 2010. While calcium channel blockers (CCBs) are often recommended as a first-line drug to treat hypertension, the effect of CCBs on the prevention of cardiovascular events, as compared with other antihypertensive drug classes, is still debated.
Topics & Concepts
MedicineClinical trialMEDLINEAntihypertensive drugAdverse effectMeta-analysisRandomized controlled trialInternal medicineIntensive care medicinePhysical therapyBlood pressureLawPolitical scienceBlood Pressure and Hypertension StudiesHormonal Regulation and HypertensionCardiac, Anesthesia and Surgical Outcomes